CALCULATION
OF REGISTRATION FEE
Title
of Each Class of Securities Offered
|
|
Maximum
Aggregate Offering Price
|
|
Amount
of Registration Fee
|
Buffered Performance Leveraged Upside Securities
due 2021
|
|
$400,000
|
|
$51.92
|
October 2019
Pricing Supplement No. 2,741
Registration Statement Nos. 333-221595;
333-221595-01
Dated October 29, 2019
Filed pursuant to Rule 424(b)(2)
Morgan
Stanley Finance LLC
Structured Investments
Opportunities in International Equities
Buffered PLUS Based on the iShares®
MSCI EAFE ETF due October 28, 2021
Buffered Performance Leveraged Upside SecuritiesSM
Fully and Unconditionally Guaranteed by Morgan Stanley
Principal at Risk Securities
The Buffered PLUS are unsecured obligations of Morgan Stanley
Finance LLC (“MSFL”) and are fully and unconditionally guaranteed by Morgan Stanley. The Buffered PLUS will pay no
interest, provide a minimum payment at maturity of only 15% of the stated principal amount and have the terms described in the
accompanying product supplement for PLUS, index supplement and prospectus, as supplemented or modified by this document. At maturity,
if the underlying shares have appreciated in value, investors will receive the stated principal amount of their investment plus
leveraged upside performance of the underlying shares, subject to the maximum payment at maturity. If the underlying shares have
depreciated in value, but the underlying shares have not declined by more than the specified buffer amount, the Buffered PLUS will
redeem for par. However, if the underlying shares have declined by more than the buffer amount, investors will lose 1% for every
1% decline beyond the specified buffer amount, subject to the minimum payment at maturity of 15% of the stated principal amount.
Investors may lose up to 85% of the stated principal amount of the Buffered PLUS. The Buffered PLUS are for investors who seek
an equity fund-based return and who are willing to risk their principal and forgo current income and upside above the maximum payment
at maturity in exchange for the leverage and buffer features that in each case apply to a limited range of performance of the underlying
shares. The Buffered PLUS are notes issued as part of MSFL’s Series A Global Medium-Term Notes program.
All payments are subject to our credit risk. If we default
on our obligations, you could lose some or all of your investment. These Buffered PLUS are not secured obligations and you will
not have any security interest in, or otherwise have any access to, any underlying reference asset or assets.
FINAL TERMS
|
Issuer:
|
Morgan Stanley Finance LLC
|
Guarantor:
|
Morgan Stanley
|
Maturity date:
|
October 28, 2021
|
Underlying shares:
|
Shares of the iShares® MSCI EAFE ETF (the “Fund”)
|
Aggregate principal amount:
|
$400,000
|
Payment at maturity per Buffered PLUS:
|
§ If
the final share price is greater than the initial share price:
$1,000 + leveraged upside payment
In no event will the
payment at maturity exceed the maximum payment at maturity.
|
|
§ If the final share price is less than or equal to the initial share price but has decreased from the initial share price by an amount less than or equal to the buffer amount of 15%: $1,000
|
|
§ If the final share price is less than the initial share price and has decreased from the initial share price by an amount greater than the buffer amount of 15%:
|
|
($1,000 x the share performance factor) + $150
|
|
Under these circumstances, the payment at maturity
will be less than the stated principal amount of $1,000.
However, under no circumstances will the
Buffered PLUS pay less than $150 per Buffered PLUS at maturity.
|
Leveraged upside payment:
|
$1,000 x leverage factor x share percent increase
|
Share percent increase:
|
(final share price – initial share price) / initial share price
|
Share performance factor:
|
final share price / initial share price
|
Initial share price:
|
$67.02, which is the closing price of one underlying share on October 25, 2019
|
Final share price:
|
The closing price of one underlying share on the valuation date times the adjustment factor on such date
|
Adjustment factor:
|
1.0, subject to adjustment in the event of certain events affecting the underlying shares
|
Valuation date:
|
October 25, 2021, subject to postponement for non-trading days and certain market disruption events
|
Leverage factor:
|
150%
|
Buffer amount:
|
15%. As a result of the buffer amount of 15%, the value at or above which the underlying shares must close on the valuation date so that investors do not suffer a loss on their initial investment in the Buffered PLUS is $56.967, which is 85% of the initial share price.
|
Minimum payment at maturity:
|
$150 per Buffered PLUS (15% of the stated principal amount)
|
Maximum payment at maturity:
|
$1,161 per Buffered PLUS (116.10% of the stated principal amount).
|
Interest:
|
None
|
Stated principal amount:
|
$1,000 per Buffered PLUS
|
Issue price:
|
$1,000 per Buffered PLUS
|
Pricing date:
|
October 29, 2019
|
Original issue date:
|
October 31, 2019 (2 business days after the pricing date)
|
CUSIP:
|
61769HF42
|
ISIN:
|
US61769HF422
|
Listing:
|
The Buffered PLUS will not be listed on any securities exchange.
|
Agent:
|
Morgan Stanley & Co. LLC (“MS & Co.”), an affiliate of MSFL and a wholly owned subsidiary of Morgan Stanley. See “Supplemental information regarding plan of distribution; conflicts of interest.”
|
Estimated value on the pricing date:
|
$985.40 per Buffered PLUS. See “Investment Summary” on page 2.
|
Commissions and issue price:
|
Price to public
|
Agent’s commissions(1)
|
Proceeds to us(2)
|
Per Buffered PLUS
|
$1,000
|
$2.50
|
$997.50
|
Total
|
$400,000
|
$1,000
|
$399,000
|
|
(1)
|
Selected dealers and their financial advisors will
collectively receive from the agent, MS & Co., a fixed sales commission of $2.50 for each Buffered PLUS they sell. See “Supplemental
information regarding plan of distribution; conflicts of interest.” For additional information, see “Plan of Distribution
(Conflicts of Interest)” in the accompanying product supplement for PLUS.
|
|
(2)
|
See “Use of proceeds and hedging” on page
16.
|
The Buffered
PLUS involve risks not associated with an investment in ordinary debt securities. See “Risk Factors” beginning on
page 6.
The Securities and Exchange Commission and
state securities regulators have not approved or disapproved these securities, or determined if this document or the accompanying
product supplement, index supplement and prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The Buffered PLUS are not deposits or savings
accounts and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency or instrumentality,
nor are they obligations of, or guaranteed by, a bank.
You should read this document together with
the related product supplement, index supplement and prospectus, each of which can be accessed via the hyperlinks below. Please
also see “Additional Terms of the Buffered PLUS” and “Additional Information About the Buffered PLUS” at
the end of this document.
As used in this document, “we,”
“us” and “our” refer to Morgan Stanley or MSFL, or Morgan Stanley and MSFL collectively, as the context
requires.
Product
Supplement for PLUS dated November 16, 2017 Index
Supplement dated November 16, 2017
Prospectus
dated November 16, 2017
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares® MSCI EAFE ETF due October 28, 2021
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
Investment Summary
Buffered Performance Leveraged Upside Securities
Principal
at Risk Securities
The Buffered PLUS Based on the iShares® MSCI EAFE
ETF due October 28, 2021 (the “Buffered PLUS”) can be used:
|
§
|
As an alternative to direct exposure to the underlying shares that enhances returns for a certain
range of positive performance of the underlying shares, subject to the maximum payment at maturity
|
|
§
|
To enhance returns and potentially outperform the underlying shares in a moderately bullish scenario
|
|
§
|
To achieve similar levels of upside exposure to the underlying shares as a direct investment,
subject to the maximum payment at maturity, while using fewer dollars by taking advantage of the leverage factor
|
|
§
|
To obtain a buffer against a specified level of negative performance in the underlying shares
|
Maturity:
|
Approximately 2 years
|
Leverage factor:
|
150%
|
Maximum payment at maturity:
|
$1,161 per Buffered PLUS (116.10% of the stated principal amount)
|
Minimum payment at maturity:
|
$150 per Buffered PLUS (15% of the stated principal amount). Investors may lose up to 85% of the stated principal amount of the Buffered PLUS.
|
Buffer amount:
|
15%
|
Coupon:
|
None
|
|
|
The original issue price of each Buffered PLUS is $1,000. This
price includes costs associated with issuing, selling, structuring and hedging the Buffered PLUS, which are borne by you, and,
consequently, the estimated value of the Buffered PLUS on the pricing date is less than $1,000. We estimate that the value of each
Buffered PLUS on the pricing date is $985.40.
What goes into the estimated value on the pricing date?
In valuing the Buffered PLUS on the pricing date, we take into
account that the Buffered PLUS comprise both a debt component and a performance-based component linked to the underlying shares.
The estimated value of the Buffered PLUS is determined using our own pricing and valuation models, market inputs and assumptions
relating to the underlying shares, instruments based on the underlying shares, volatility and other factors including current and
expected interest rates, as well as an interest rate related to our secondary market credit spread, which is the implied interest
rate at which our conventional fixed rate debt trades in the secondary market.
What determines the economic terms of the Buffered PLUS?
In determining the economic terms of the Buffered PLUS, including
the leverage factor, the maximum payment at maturity, the buffer amount and the minimum payment at maturity, we use an internal
funding rate, which is likely to be lower than our secondary market credit spreads and therefore advantageous to us. If the issuing,
selling, structuring and hedging costs borne by you were lower or if the internal funding rate were higher, one or more of the
economic terms of the Buffered PLUS would be more favorable to you.
What is the relationship between the estimated value on the
pricing date and the secondary market price of the Buffered PLUS?
The price at which MS & Co. purchases the Buffered PLUS in
the secondary market, absent changes in market conditions, including those related to the underlying shares, may vary from, and
be lower than, the estimated value on the pricing date, because the secondary market price takes into account our secondary market
credit spread as well as the bid-offer spread that MS & Co. would charge in a secondary market transaction of this type and
other factors. However, because the costs associated with issuing, selling, structuring and hedging the Buffered PLUS are not fully
deducted upon issuance, for a period of up to 6 months following the issue date, to the extent that MS & Co. may buy or sell
the Buffered PLUS in the secondary market, absent changes in market conditions, including those related to the underlying shares,
and to our secondary market credit spreads, it would do so based on values higher than the estimated value. We expect that those
higher values will also be reflected in your brokerage account statements.
MS & Co. may, but is not obligated to, make a market in the
Buffered PLUS, and, if it once chooses to make a market, may cease doing so at any time.
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares® MSCI EAFE ETF due October 28, 2021
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
Key Investment Rationale
The Buffered PLUS offer leveraged upside exposure to the underlying
shares, subject to the maximum payment at maturity, while providing limited protection against negative performance of the underlying
shares. Once the underlying shares have decreased in price by more than a specified buffer amount, investors are exposed to the
negative performance of the underlying shares, subject to the minimum payment at maturity. At maturity, if the underlying shares
have appreciated, investors will receive the stated principal amount of their investment plus leveraged upside performance of the
underlying shares, subject to the maximum payment at maturity. At maturity, if the underlying shares have depreciated and (i) if
the closing price of the underlying shares has not declined from the initial share price by more than the specified buffer amount,
the Buffered PLUS will redeem for par, or (ii) if the closing price of the underlying shares has declined by more than the buffer
amount, the investor will lose 1% for every 1% decline beyond the specified buffer amount, subject to the minimum payment at maturity.
Investors may lose up to 85% of the stated principal amount of the Buffered PLUS.
Leveraged Performance up to a Cap
|
The Buffered PLUS offer investors an opportunity to capture enhanced returns for a certain range of positive performance relative to a direct investment in the underlying shares, subject to the maximum payment at maturity.
|
Upside Scenario
|
The underlying shares increase in price, and, at maturity, the Buffered PLUS redeem for the stated principal amount of $1,000 plus 150% of the share return, subject to the maximum payment at maturity of $1,161 per Buffered PLUS (116.10% of the stated principal amount).
|
Par Scenario
|
The underlying shares decline in price by no more than 15%, and, at maturity, the Buffered PLUS redeem for the stated principal amount of $1,000.
|
Downside Scenario
|
The underlying shares decline in price by more than 15%, and, at maturity, the Buffered PLUS redeem for less than the stated principal amount by an amount that is proportionate to the percentage decrease of the underlying shares from the initial share price, plus the buffer amount of 15%. (Example: if the underlying shares decrease in price by 35%, investors would lose 20% of their principal and the Buffered PLUS will redeem for $800, or 80% of the stated principal amount.) The minimum payment at maturity is $150 per Buffered PLUS.
|
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares® MSCI EAFE ETF due October 28, 2021
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
How the Buffered PLUS Work
Payoff Diagram
The payoff diagram below illustrates the payment at maturity
on the Buffered PLUS based on the following terms:
Stated principal amount:
|
$1,000 per Buffered PLUS
|
Leverage factor:
|
150%
|
Buffer amount:
|
15%
|
Maximum payment at maturity:
|
$1,161 per Buffered PLUS (116.10% of the stated principal amount)
|
Minimum payment at maturity:
|
$150 per Buffered PLUS
|
|
|
Buffered PLUS Payoff Diagram
|
|
How it works
|
§
|
Upside Scenario. If the final share
price is greater than the initial share price, investors will receive the $1,000 stated principal amount plus 150% of the appreciation
of the underlying shares over the term of the Buffered PLUS, subject to the maximum payment at maturity. An investor will realize
the maximum payment at maturity of $1,161 per Buffered PLUS (116.10% of the stated principal amount) at a final share price of
approximately 110.73% of the initial share price.
|
|
§
|
If the value of the underlying shares appreciates 2%, the investor would receive a 3% return,
or $1,030 per Buffered PLUS.
|
|
§
|
If the value of the underlying shares appreciates 40%, the investor would receive only the maximum
payment at maturity of $1,161 per Buffered PLUS, or 116.10% of the stated principal amount.
|
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares® MSCI EAFE ETF due October 28, 2021
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
|
§
|
Par Scenario. If the final share
price is less than or equal to the initial share price but has decreased from the initial share price by an amount less than or
equal to the buffer amount of 15%, investors will receive the stated principal amount of $1,000 per Buffered PLUS.
|
|
§
|
Downside Scenario. If the final share
price is less than the initial share price and has decreased from the initial share price by an amount greater than the buffer
amount of 15%, investors will receive an amount that is less than the stated principal amount by an amount that is proportionate
to the percentage decrease in the value of the underlying shares from the initial share price, plus the buffer amount of 15%. The
minimum payment at maturity is $150 per Buffered PLUS.
|
|
§
|
For example, if the value of the underlying shares depreciates 45%, investors would lose 30%
of their principal and receive only $700 per Buffered PLUS at maturity, or 70% of the stated principal amount.
|
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares® MSCI EAFE ETF due October 28, 2021
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
Risk Factors
The following is a non-exhaustive list of certain key risk
factors for investors in the Buffered PLUS. For further discussion of these and other risks, you should read the section entitled
“Risk Factors” in the accompanying product supplement for PLUS, index supplement and prospectus. You should also consult
with your investment, legal, tax, accounting and other advisers in connection with your investment in the Buffered PLUS.
|
§
|
Buffered PLUS do not pay interest and provide a minimum payment at maturity of only 15% of your principal. The terms
of the Buffered PLUS differ from those of ordinary debt securities in that the Buffered PLUS do not pay interest, and provide a
minimum payment at maturity of only 15% of the stated principal amount of the Buffered PLUS, subject to our credit risk. If the
final share price is less than 85% of the initial share price, you will receive for each Buffered PLUS that you hold a payment
at maturity that is less than the stated principal amount of each Buffered PLUS by an amount proportionate to the decline in the
closing value of the underlying shares from the initial share price, plus $150 per Buffered PLUS. Accordingly, investors may
lose up to 85% of the stated principal amount of the Buffered PLUS.
|
|
§
|
The appreciation potential of the Buffered PLUS is limited by the maximum payment at maturity. The appreciation potential
of the Buffered PLUS is limited by the maximum payment at maturity of $1,161 per Buffered PLUS, or 116.10% of the stated principal
amount. Although the leverage factor provides 150% exposure to any increase in the final share price over the initial share price,
because the payment at maturity will be limited to 116.10% of the stated principal amount for the Buffered PLUS, any increase in
the final share price over the initial share price by more than approximately 10.73% of the initial share price will not further
increase the return on the Buffered PLUS.
|
|
§
|
The market price of the Buffered PLUS will be influenced by many unpredictable factors. Several
factors, many of which are beyond our control, will influence the value of the Buffered PLUS in the secondary market and the price
at which MS & Co. may be willing to purchase or sell the Buffered PLUS in the secondary market, including the trading price,
volatility (frequency and magnitude of changes in value) and dividends of the underlying shares and of the stocks composing the
MSCI EAFE IndexSM, interest
and yield rates in the market, time remaining until the Buffered PLUS mature, geopolitical
conditions and economic, financial, political, regulatory or judicial events that affect the underlying shares or equities markets
generally and which may affect the final share price of the underlying shares, the exchange rates relative to the U.S. dollar with
respect to each of the currencies in which the shares comprising the MSCI EAFE IndexSM
trade, the occurrence of certain events affecting the underlying shares that may or may not require
an adjustment to the adjustment factor, and any actual or anticipated changes in our credit ratings or credit spreads. The price
of the underlying shares may be, and has recently been, volatile, and we can give you no assurance that the volatility will lessen.
See “iShares® MSCI EAFE ETF Overview” below. You may receive
less, and possibly significantly less, than the stated principal amount per Buffered PLUS if you try to sell your Buffered PLUS
prior to maturity.
|
|
§
|
The Buffered PLUS are subject to our credit risk, and any actual or anticipated changes to our credit ratings or credit
spreads may adversely affect the market value of the Buffered PLUS. You are dependent on our ability to pay all amounts due
on the Buffered PLUS at maturity and therefore you are subject to our credit risk. If we default on our obligations under the Buffered
PLUS, your investment would be at risk and you could lose some or all of your investment. As a result, the market value of the
Buffered PLUS prior to maturity will be affected by changes in the market’s view of our creditworthiness. Any actual or anticipated
decline in our credit ratings or increase in the credit spreads charged by the market for taking our credit risk is likely to adversely
affect the market value of the Buffered PLUS.
|
|
§
|
As a finance subsidiary, MSFL has no independent operations and will have no independent assets. As a finance subsidiary,
MSFL has no independent operations beyond the issuance and administration of its securities and will have no independent assets
available for distributions to holders of MSFL securities if they make claims in respect of such securities in a bankruptcy, resolution
or similar proceeding. Accordingly, any recoveries by such holders will be limited to those available under the related guarantee
by Morgan Stanley and that guarantee will rank pari passu with all other unsecured, unsubordinated obligations of Morgan
Stanley. Holders will have recourse only to a single claim against Morgan Stanley and its assets under the guarantee. Holders of
securities issued by MSFL should accordingly assume that in any such proceedings they would not have any priority over and should
be
|
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares® MSCI EAFE ETF due October 28, 2021
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
treated pari passu with
the claims of other unsecured, unsubordinated creditors of Morgan Stanley, including holders of Morgan Stanley-issued securities.
|
§
|
The amount payable on the Buffered PLUS is not linked to the value of the underlying shares at any time other than the valuation
date. The final share price will be based on the closing price on the valuation date, subject to postponement for non-trading
days and certain market disruption events. Even if the value of the underlying shares appreciates prior to the valuation date but
then drops by the valuation date by more than 15%, the payment at maturity will be less, and may be significantly less, than it
would have been had the payment at maturity been linked to the value of the underlying shares prior to such drop. Although the
actual value of the underlying shares on the stated maturity date or at other times during the term of the Buffered PLUS may be
higher than the closing price on the valuation date, the payment at maturity will be based solely on the closing price on the valuation
date.
|
|
§
|
Investing in the Buffered PLUS is not equivalent to investing in the underlying shares or the stocks composing the MSCI
EAFE IndexSM. Investing in the Buffered
PLUS is not equivalent to investing in the underlying shares, the MSCI EAFE IndexSM
(the “share underlying index”) or the stocks that constitute the MSCI EAFE
IndexSM.
Investors in the Buffered PLUS will not have voting rights or rights to receive dividends or other distributions or any other rights
with respect to the underlying shares or the stocks that constitute the MSCI EAFE IndexSM.
|
|
§
|
The price of the underlying shares is subject to currency exchange risk. Because the
price of the underlying shares is related to the U.S. dollar value of stocks underlying the MSCI EAFE IndexSM,
holders of the Buffered PLUS will be exposed to currency exchange rate risk with respect to each of the currencies in which such
component securities trade. Exchange rate movements for a particular currency are volatile and are the result of numerous factors
including the supply of, and the demand for, those currencies, as well as relevant government policy, intervention or actions,
but are also influenced significantly from time to time by political or economic developments, and by macroeconomic factors and
speculative actions related to the relevant region. An investor’s net exposure will depend on the extent to which the currencies
of the component securities strengthen or weaken against the U.S. dollar and the relative weight of each currency. If, taking into
account such weighting, the dollar strengthens against the currencies of the component securities represented in the MSCI
EAFE IndexSM,
the price of the underlying shares will be adversely affected and the payment at maturity on the Buffered PLUS may be reduced.
|
Of
particular importance to potential currency exchange risk are:
|
·
|
existing and expected rates of inflation;
|
|
·
|
existing and expected interest rate levels;
|
|
·
|
the balance of payments; and
|
|
·
|
the extent of governmental surpluses or deficits in the countries represented in the MSCI
EAFE IndexSM and
the United States.
|
All
of these factors are in turn sensitive to the monetary, fiscal and trade policies pursued by the governments of various countries
represented in the MSCI EAFE IndexSM
and the United States and other countries important to international trade and finance.
|
§
|
There are risks associated with investments in securities, such as the Buffered PLUS, linked to the value of foreign equity
securities. The underlying shares track the performance of the MSCI EAFE IndexSM,
which is linked to the value of foreign equity securities. Investments in securities linked to the value of foreign equity securities
involve risks associated with the securities markets in those countries, including risks of volatility in those markets, governmental
intervention in those markets and cross-shareholdings in companies in certain countries. Also, there is generally less publicly
available information about foreign companies than about U.S. companies that are subject to the reporting requirements of the Securities
and Exchange Commission, and foreign companies are subject to accounting, auditing and financial reporting standards and requirements
different from those applicable to U.S. reporting companies. The prices of securities issued in foreign markets may be affected
by political, economic, financial and social factors in those countries, or global regions, including changes in government, economic
and fiscal policies and currency exchange laws. Local securities markets may trade a small number of securities and may be unable
to respond effectively to increases in trading volume, potentially making prompt liquidation of holdings difficult or impossible
at times. Moreover, the economies in such countries may differ
|
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares® MSCI EAFE ETF due October 28, 2021
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
unfavorably from the economy
in the United States in such respects as growth of gross national product, rate of inflation, capital reinvestment, resources,
self-sufficiency and balance of payment positions between countries.
|
§
|
Adjustments to the underlying shares or to the EAFE IndexSM could
adversely affect the value of the Buffered PLUS. As the investment adviser to the iShares®
MSCI EAFE IndexSM, BlackRock Fund Advisors
(the “Investment Adviser”), seeks investment results that correspond generally
to the price and yield performance, before fees and expenses, of the MSCI EAFE IndexSM.
Pursuant to its investment strategy or otherwise, the Investment Adviser may add, delete or substitute the stocks composing the
iShares® MSCI EAFE ETF. Any of these actions could adversely affect the price of the underlying shares and, consequently,
the value of the Buffered PLUS. MSCI Inc. (“MSCI”) is responsible for calculating and maintaining the MSCI EAFE IndexSM.
MSCI may add, delete or substitute the stocks constituting the MSCI EAFE IndexSM
or make other methodological changes that could change the value of the MSCI EAFE IndexSM.
MSCI may discontinue or suspend calculation or publication of the MSCI EAFE IndexSM
at any time. In these circumstances, the calculation agent will have the sole discretion to substitute a successor index that is
comparable to the discontinued MSCI EAFE IndexSM
and is permitted to consider indices that are calculated and published by the calculation agent or any of its affiliates.
|
|
§
|
The performance and market price of the Fund, particularly during periods of market volatility, may not correlate with the
performance of the share underlying index, the performance of the component securities of the share underlying index or the net
asset value per share of the Fund. The Fund does not fully replicate the share underlying index and may hold securities
that are different than those included in the share underlying index. In addition, the performance of the Fund will reflect
additional transaction costs and fees that are not included in the calculation of the share underlying index. All of these
factors may lead to a lack of correlation between the performance of the Fund and the share underlying index. In addition,
corporate actions (such as mergers and spin-offs) with respect to the equity securities underlying the Fund may impact the variance
between the performances of the Fund and the share underlying index. Finally, because the shares of the Fund are traded on
an exchange and are subject to market supply and investor demand, the market price of one share of the Fund may differ from
the net asset value per share of the Fund.
|
In particular, during periods of
market volatility, or unusual trading activity, trading in the securities underlying the Fund may be disrupted or limited, or such
securities may be unavailable in the secondary market. Under these circumstances, the liquidity of the Fund may be adversely
affected, market participants may be unable to calculate accurately the net asset value per share of the Fund, and their ability
to create and redeem shares of the Fund may be disrupted. Under these circumstances, the market price of shares of the Fund may
vary substantially from the net asset value per share of the Fund or the level of the share underlying index.
For all of the foregoing reasons,
the performance of the Fund may not correlate with the performance of the share underlying index, the performance of the component
securities of the share underlying index or the net asset value per share of the Fund. Any of these events could materially
and adversely affect the price of the shares of the Fund and, therefore, the value of the Buffered PLUS. Additionally, if
market volatility or these events were to occur on the valuation date, the calculation agent would maintain discretion to determine
whether such market volatility or events have caused a market disruption event to occur, and such determination would affect the
payment at maturity of the Buffered PLUS. If the calculation agent determines that no market disruption event has taken place,
the payment at maturity would be based solely on the published closing price per share of the Fund on the valuation date, even
if the Fund’s shares are underperforming the share underlying index or the component securities of the share underlying index
and/or trading below the net asset value per share of the Fund.
|
§
|
The rate we are willing to pay for securities of this type, maturity and issuance size is likely to be lower than the rate
implied by our secondary market credit spreads and advantageous to us. Both the lower rate and the inclusion of costs associated
with issuing, selling, structuring and hedging the Buffered PLUS in the original issue price reduce the economic terms of the Buffered
PLUS, cause the estimated value of the Buffered PLUS to be less than the original issue price and will adversely affect secondary
market prices. Assuming no change in market conditions or any other relevant factors, the prices, if any, at which dealers,
including MS & Co., may be willing to purchase the Buffered PLUS in secondary market transactions will likely be significantly
lower than the original issue price, because secondary market prices will exclude the issuing, selling, structuring and hedging-related
costs that are included in the original issue price and borne by you and because the secondary market prices will reflect our secondary
market credit spreads and the bid-offer spread that any dealer would charge in a secondary market transaction of this type as well
as other factors.
|
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares® MSCI EAFE ETF due October 28, 2021
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
The inclusion of the costs of issuing,
selling, structuring and hedging the Buffered PLUS in the original issue price and the lower rate we are willing to pay as issuer
make the economic terms of the Buffered PLUS less favorable to you than they otherwise would be.
However, because the costs associated
with issuing, selling, structuring and hedging the Buffered PLUS are not fully deducted upon issuance, for a period of up to 6
months following the issue date, to the extent that MS & Co. may buy or sell the Buffered PLUS in the secondary market, absent
changes in market conditions, including those related to the underlying shares, and to our secondary market credit spreads, it
would do so based on values higher than the estimated value, and we expect that those higher values will also be reflected in your
brokerage account statements.
|
§
|
The estimated value of the Buffered PLUS is determined by reference to our pricing and valuation models, which may differ
from those of other dealers and is not a maximum or minimum secondary market price. These pricing and valuation models are
proprietary and rely in part on subjective views of certain market inputs and certain assumptions about future events, which may
prove to be incorrect. As a result, because there is no market-standard way to value these types of securities, our models may
yield a higher estimated value of the Buffered PLUS than those generated by others, including other dealers in the market, if they
attempted to value the Buffered PLUS. In addition, the estimated value on the pricing date does not represent a minimum or maximum
price at which dealers, including MS & Co., would be willing to purchase your Buffered PLUS in the secondary market (if any
exists) at any time. The value of your Buffered PLUS at any time after the date of this document will vary based on many factors
that cannot be predicted with accuracy, including our creditworthiness and changes in market conditions. See also “The market
price of the Buffered PLUS will be influenced by many unpredictable factors” above.
|
|
§
|
The antidilution adjustments the calculation agent is required to make do not cover every event that could affect the shares
of the iShares® MSCI EAFE ETF. MS & Co., as calculation agent, will adjust the amount payable at maturity
for certain events affecting the shares of the iShares® MSCI EAFE ETF.
However, the calculation agent will not make an adjustment for every event that could affect the shares of the iShares®
MSCI EAFE ETF. If an event occurs that does not require the calculation agent to adjust the adjustment factor, the market
price of the Buffered PLUS may be materially and adversely affected.
|
|
§
|
The Buffered PLUS will not be listed on any securities exchange and secondary trading may be limited. The Buffered PLUS
will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the Buffered PLUS. MS
& Co. may, but is not obligated to, make a market in the Buffered PLUS and, if it once chooses to make a market, may cease
doing so at any time. When it does make a market, it will generally do so for transactions of routine secondary market size at
prices based on its estimate of the current value of the Buffered PLUS, taking into account its bid/offer spread, our credit spreads,
market volatility, the notional size of the proposed sale, the cost of unwinding any related hedging positions, the time remaining
to maturity and the likelihood that it will be able to resell the Buffered PLUS. Even if there is a secondary market, it may not
provide enough liquidity to allow you to trade or sell the Buffered PLUS easily. Since other broker-dealers may not participate
significantly in the secondary market for the Buffered PLUS, the price at which you may be able to trade your Buffered PLUS is
likely to depend on the price, if any, at which MS & Co. is willing to transact. If, at any time, MS & Co. were to cease
making a market in the Buffered PLUS, it is likely that there would be no secondary market for the Buffered PLUS. Accordingly,
you should be willing to hold your Buffered PLUS to maturity.
|
|
§
|
The calculation agent, which is a subsidiary of Morgan Stanley and an affiliate of MSFL, will make determinations with respect
to the Buffered PLUS. As calculation agent, MS & Co. has determined the initial share price, will determine the final share
price and will calculate the amount of cash you receive at maturity. Moreover, certain determinations made by MS & Co. in its
capacity as calculation agent, may require it to exercise discretion and make subjective judgements, such as with respect to the
occurrence or non-occurrence of market disruption events and the selection of a successor index or calculation of the final share
price in the event of a market disruption event or discontinuance of the MSCI EAFE IndexSM.
These potentially subjective determinations may adversely affect the payout to you at maturity. For further information
regarding these type of determinations, see “Description of PLUS—Postponement of Valuation Date(s)” and “—Calculation
Agent and Calculations” in the accompanying product supplement. In addition, MS & Co. has determined the estimated value
of the Buffered PLUS on the pricing date.
|
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares® MSCI EAFE ETF due October 28, 2021
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
|
§
|
Hedging and trading activity by our affiliates could potentially adversely affect the value of the Buffered PLUS. One
or more of our affiliates and/or third-party dealers have carried out, and will continue to carry out, hedging activities related
to the Buffered PLUS (and to other instruments linked to the underlying shares or the MSCI EAFE IndexSM),
including trading in the underlying shares and in other instruments related to the underlying shares or the MSCI EAFE IndexSM.
As a result, these entities may be unwinding or adjusting hedge positions during the term of the Buffered PLUS, and the hedging
strategy may involve greater and more frequent dynamic adjustments to the hedge as the valuation date approaches. Some of our affiliates
also trade the underlying shares or the stocks that constitute the MSCI EAFE IndexSM
and other financial instruments related to the MSCI EAFE IndexSM on a regular basis as part of their general broker-dealer
and other businesses. Any of these hedging or trading activities on or prior to October 25, 2019 could have increased the initial
share price, and, therefore, could have increased the price at or above which the shares of the iShares®
MSCI EAFE ETF must close on the valuation date so that investors do not suffer a loss on their initial investment in the
Buffered PLUS. Additionally, such hedging or trading activities during the term of the Buffered PLUS, including on the valuation
date, could adversely affect the closing price of the shares of the iShares® MSCI
EAFE ETF on the valuation date, and, accordingly, the amount of cash an investor will receive at maturity.
|
|
§
|
The U.S. federal income tax consequences of an investment in the Buffered PLUS are uncertain. Please read the discussion
under “Additional Information—Tax considerations” in this document and the discussion under “United States
Federal Taxation” in the accompanying product supplement for PLUS (together, the “Tax Disclosure Sections”) concerning
the U.S. federal income tax consequences of an investment in the Buffered PLUS. As discussed in the Tax Disclosure Sections, there
is a substantial risk that the “constructive ownership” rule could apply, in which case all or a portion of any long-term
capital gain recognized by a U.S. Holder could be recharacterized as ordinary income and an interest charge could be imposed. If
the Internal Revenue Service (the “IRS”) were successful in asserting an alternative treatment, the timing and character
of income on the Buffered PLUS might differ significantly from the tax treatment described in the Tax Disclosure Sections. There
is a risk that the IRS may seek to treat all or a portion of the gain on the Buffered PLUS as ordinary income. For example, there
is a risk that the IRS could seek to recharacterize the Buffered PLUS as debt instruments. In that event, U.S. Holders would be
required to accrue into income original issue discount on the Buffered PLUS every year at a “comparable yield” determined
at the time of issuance and recognize all income and gain in respect of the Buffered PLUS as ordinary income. Additionally, as
discussed under “United States Federal Taxation—FATCA” in the accompanying product supplement for PLUS, the withholding
rules commonly referred to as “FATCA” would apply to the Buffered PLUS if they were recharacterized as debt instruments.
However, recently proposed regulations (the preamble to which specifies that taxpayers are permitted to rely on them pending finalization)
eliminate the withholding requirement on payments of gross proceeds of a taxable disposition (other than amounts treated as “FDAP
income,” as defined in the accompanying product supplement for PLUS). The risk that financial instruments providing for buffers,
triggers or similar downside protection features, such as the Buffered PLUS, would be recharacterized as debt is greater than the
risk of recharacterization for comparable financial instruments that do not have such features. We do not plan to request a ruling
from the IRS regarding the tax treatment of the Buffered PLUS, and the IRS or a court may not agree with the tax treatment described
in the Tax Disclosure Sections.
|
In 2007, the U.S. Treasury Department
and the IRS released a notice requesting comments on the U.S. federal income tax treatment of “prepaid forward contracts”
and similar instruments. The notice focuses in particular on whether to require holders of these instruments to accrue income over
the term of their investment. It also asks for comments on a number of related topics, including the character of income or loss
with respect to these instruments; whether short-term instruments should be subject to any such accrual regime; the relevance of
factors such as the exchange-traded status of the instruments and the nature of the underlying property to which the instruments
are linked; the degree, if any, to which income (including any mandated accruals) realized by non-U.S. investors should be subject
to withholding tax; and whether these instruments are or should be subject to the “constructive ownership” rule, as
discussed in this document. While the notice requests comments on appropriate transition rules and effective dates, any Treasury
regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences
of an investment in the Buffered PLUS, possibly with retroactive effect. Both U.S. and Non-U.S. Holders should consult their tax
advisers regarding the U.S. federal income tax consequences of an investment in the Buffered PLUS, including possible alternative
treatments, the potential application of the constructive ownership rule, the issues presented by this notice and any tax consequences
arising under the laws of any state, local or non-U.S. taxing jurisdiction.
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares® MSCI EAFE ETF due October 28, 2021
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
iShares® MSCI EAFE ETF Overview
The iShares® MSCI EAFE ETF is an exchange-traded
fund that seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the
MSCI EAFE IndexSM. The iShares® MSCI EAFE ETF is managed by iShares Trust (“iShares”),
a registered investment company that consists of numerous separate investment portfolios, including the iShares® MSCI
EAFE ETF. Information provided to or filed with the Securities and Exchange Commission (the “Commission”) by iShares
pursuant to the Securities Act of 1933 and the Investment Company Act of 1940 can be located by reference to Commission file numbers
333-92935 and 811-09729, respectively, through the Commission’s website at www.sec.gov. In addition, information may be obtained
from other publicly available sources. Neither the issuer nor the agent makes any representation that any such publicly available
information regarding the iShares® MSCI EAFE ETF is accurate or complete.
Information as of market close on October 29, 2019:
Bloomberg Ticker Symbol:
|
EFA UP
|
Current Share Price:
|
$67.30
|
52 Weeks Ago:
|
$61.26
|
52 Week High (on 10/28/2019):
|
$67.32
|
52 Week Low (on 12/24/2018):
|
$56.89
|
|
|
The following graph sets forth
the daily closing price of the underlying shares for the period from January 1, 2014 through October 29, 2019. The related table
sets forth the published high and low closing prices as well as the end-of-quarter closing prices of the underlying shares for
each quarter in the same period. The closing price of the underlying shares on October 29, 2019 was $67.30. We obtained the information
in the table and graph below from Bloomberg Financial Markets, without independent verification. The historical prices of the underlying
shares should not be taken as an indication of future performance, and no assurance can be given as to the closing price of the
underlying shares on the valuation date.
Shares of the iShares® MSCI EAFE ETF
Daily Closing Prices
January 1, 2014 to October 29, 2019
|
|
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares® MSCI EAFE ETF due October 28, 2021
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
iShares® MSCI EAFE ETF (CUSIP 464287465)
|
High ($)
|
Low ($)
|
Period End ($)
|
2014
|
|
|
|
First Quarter
|
68.03
|
62.31
|
67.17
|
Second Quarter
|
70.67
|
66.26
|
68.37
|
Third Quarter
|
69.25
|
64.12
|
64.12
|
Fourth Quarter
|
64.51
|
59.53
|
60.84
|
2015
|
|
|
|
First Quarter
|
65.99
|
58.48
|
64.17
|
Second Quarter
|
68.42
|
63.49
|
63.49
|
Third Quarter
|
65.46
|
56.25
|
57.32
|
Fourth Quarter
|
62.06
|
57.50
|
59.73
|
2016
|
|
|
|
First Quarter
|
57.82
|
51.38
|
57.16
|
Second Quarter
|
59.87
|
52.63
|
55.82
|
Third Quarter
|
59.86
|
54.42
|
59.13
|
Fourth Quarter
|
59.20
|
56.20
|
57.73
|
2017
|
|
|
|
First Quarter
|
62.60
|
58.09
|
62.29
|
Second Quarter
|
67.22
|
61.44
|
65.20
|
Third Quarter
|
68.48
|
64.83
|
68.48
|
Fourth Quarter
|
70.80
|
68.42
|
70.31
|
2018
|
|
|
|
First Quarter
|
75.25
|
67.94
|
69.68
|
Second Quarter
|
71.90
|
66.35
|
66.97
|
Third Quarter
|
68.98
|
65.43
|
67.99
|
Fourth Quarter
|
68.07
|
56.89
|
58.78
|
2019
|
|
|
|
First Quarter
|
65.61
|
58.13
|
64.86
|
Second Quarter
|
66.99
|
63.40
|
65.73
|
Third Quarter
|
66.68
|
61.30
|
65.21
|
Fourth Quarter (through October 29, 2019)
|
67.32
|
63.25
|
67.30
|
|
|
|
|
This document relates only to the Buffered PLUS referenced
hereby and does not relate to the underlying shares. We have derived all disclosures contained in this document regarding iShares
from the publicly available documents described in the preceding paragraph. In connection with the offering of the Buffered PLUS,
neither we nor the agent has participated in the preparation of such documents or made any due diligence inquiry with respect to
iShares. Neither we nor the agent makes any representation that such publicly available documents or any other publicly available
information regarding iShares is accurate or complete. Furthermore, we cannot give any assurance that all events occurring prior
to the date hereof (including events that would affect the accuracy or completeness of the publicly available documents described
in the preceding paragraph) that would affect the trading price of the underlying shares (and therefore the price of the underlying
shares at the time we priced the Buffered PLUS) have been publicly disclosed. Subsequent disclosure of any such events or the disclosure
of or failure to disclose material future events concerning iShares could affect the value received at maturity with respect to
the Buffered PLUS and therefore the value of the Buffered PLUS.
Neither we nor any of our affiliates makes any representation
to you as to the performance of the underlying shares.
We and/or our affiliates may presently or from time to time engage
in business with iShares. In the course of such business, we and/or our affiliates may acquire non-public information with respect
to iShares, and neither we nor any of our affiliates undertakes to disclose any such information to you. In addition, one or more
of our affiliates may publish research reports with respect to the underlying shares. The statements in the preceding two sentences
are not intended to affect the rights of investors in the Buffered PLUS under the securities laws. As a purchaser of the Buffered
PLUS, you should undertake an independent investigation of iShares as in your judgment is appropriate to make an informed decision
with respect to an investment linked to the underlying shares.
iShares® is a registered trademark of BlackRock
Institutional Trust Company, N.A. (“BTC”). The Buffered PLUS are not sponsored, endorsed, sold, or promoted by BTC.
BTC makes no representations or warranties to the owners of the Buffered PLUS or any member of the public regarding the advisability
of investing in the Buffered PLUS. BTC has no obligation or liability in connection with the operation, marketing, trading or sale
of the Buffered PLUS.
The MSCI EAFE IndexSM. The
MSCI EAFE IndexSM is a stock index calculated, published and disseminated daily by MSCI Inc. (“MSCI”).
The index is a free float-adjusted market capitalization index that is designed to measure the equity market
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares® MSCI EAFE ETF due October 28, 2021
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
performance of developed markets, excluding the United States
and Canada, and it consists of the following 21 developed market country indices: Australia, Austria, Belgium, Denmark, Finland,
France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, the Netherlands, New Zealand, Norway, Portugal, Singapore, Spain, Sweden,
Switzerland and the United Kingdom. For additional information about the MSCI EAFE IndexSM, see the information set
forth under “MSCI EAFE IndexSM” and “MSCI Global Investable Market Indices Methodology” in the
accompanying index supplement.
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares® MSCI EAFE ETF due October 28, 2021
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
Additional Terms of the Buffered PLUS
Please read this information
in conjunction with the summary terms on the front cover of this document.
Additional Terms:
|
|
If the terms described herein are inconsistent with those described in the accompanying product supplement, index supplement or prospectus, the terms described herein shall control.
|
Share underlying index:
|
The MSCI EAFE IndexSM
|
Share underlying index publisher:
|
MSCI Inc. or any successor thereof
|
Postponement of
maturity date:
|
If the scheduled valuation date is not a trading day or if a market disruption event occurs on that day so that the valuation date as postponed falls less than two business days prior to the scheduled maturity date, the maturity date of the Buffered PLUS will be postponed to the second business day following that valuation date as postponed.
|
Denominations:
|
$1,000 per Buffered PLUS and integral multiples thereof
|
Trustee:
|
The Bank of New York Mellon
|
Calculation agent:
|
MS & Co.
|
Issuer notice to registered security holders, the trustee and the depositary:
|
In the event that the maturity date is postponed due to postponement
of the valuation date, the issuer shall give notice of such postponement and, once it has been determined, of the date to which
the maturity date has been rescheduled (i) to each registered holder of the Buffered PLUS by mailing notice of such postponement
by first class mail, postage prepaid, to such registered holder’s last address as it shall appear upon the registry books,
(ii) to the trustee by facsimile confirmed by mailing such notice to the trustee by first class mail, postage prepaid, at its New
York office and (iii) to The Depository Trust Company (the “depositary”) by telephone or facsimile, confirmed by mailing
such notice to the depositary by first class mail, postage prepaid. Any notice that is mailed to a registered holder of the Buffered
PLUS in the manner herein provided shall be conclusively presumed to have been duly given to such registered holder, whether or
not such registered holder receives the notice. The issuer shall give such notice as promptly as possible, and in no case later
than (i) with respect to notice of postponement of the maturity date, the business day immediately preceding the scheduled maturity
date and (ii) with respect to notice of the date to which the maturity date has been rescheduled, the business day immediately
following the actual valuation date.
The issuer shall, or shall cause the calculation agent to, (i)
provide written notice to the trustee and to the depositary of the amount of cash to be delivered with respect to each stated principal
amount of the Buffered PLUS, on or prior to 10:30 a.m. (New York City time) on the business day preceding the maturity date, and
(ii) deliver the aggregate cash amount due with respect to the Buffered PLUS to the trustee for delivery to the depositary, as
holder of the Buffered PLUS, on the maturity date.
|
Morgan Stanley Finance LLC
Buffered PLUS Based on the iShares® MSCI EAFE ETF due October 28, 2021
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
Additional Information About the Buffered PLUS